HA

Haemonetics CorpNYSE HAE Stock Report

Last reporting period 28 Sep, 2024

Updated 20 Dec, 2024

Last price

Market cap $B

3.863

Middle

Exchange

XNYS - New York Stock Exchange, Inc

View Section: Company Analysis

Haemonetics Rating

HA

HAE stock rating score is 41/100. Haemonetics is aExtremely Risky Investment.

The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.

Eyestock Rating

Last update 12.11.2024

41/100

Low score

Rating Breakdown

  • Profitability score

    12

    /25

  • Solvency score

    10

    /25

  • Efficiency score

    14

    /25

  • Stability score

    5

    /25

Haemonetics Corp Rewards and Warnings

The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.

Financial

Check

Value

Net Profit Margin

9 %

Earnings quality

69 %

Gross Margin

54 %

Haemonetics Corp's Historical Rating

How has the company's valuation changed in the past?

A quick analysis will help you understand how stable financial indicators are overall.


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Discover High-rated Companies


View Section: Valuation